SCHEMBL18673137

SCHEMBL18673137

C=C/C=C\C(=C/C=C)C(C)=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2737129 0.83 ALDH1A1 (0.35) ALDH1A1
SCHEMBL13786730 0.81 ALDH1A1 (0.33) ALDH1A1
SCHEMBL22292182 0.80
SCHEMBL18410418 0.80
SCHEMBL361538 0.79 ALDH1A1 (0.32) ALDH1A1
SCHEMBL19325374 0.79
SCHEMBL18389724 0.78 LMNA (0.30)
SCHEMBL28298539 0.78 LMNA (0.30)
SCHEMBL19333071 0.78 ALDH1A1 (0.30) ALDH1A1
SCHEMBL22292183 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235097-A1 DEXTRAN-ALPHA-GLUCAN GRAFT COPOLYMERS AND DERIVATIVES THEREOF NUTRITION & BIOSCIENCES USA 4 INC. 2023-07-27 US disclosed
US-20230042356-A1 WHITENING ADDITIVE THE PROCTER & GAMBLE COMPANY 2023-02-09 US disclosed
US-11185839-B2 Reconfigurable multi-step chemical synthesis system and related components and methods MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-11-30 US disclosed
US-20210107853-A1 SYNTHESIS OF MONO-CHLORINATED ACETOPHENONE SIEGFRIED AG (CH) 2021-04-15 US disclosed
US-20190126229-A1 RECONFIGURABLE MULTI-STEP CHEMICAL SYNTHESIS SYSTEM AND RELATED COMPONENTS AND METHODS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2019-05-02 US disclosed
US-10005902-B2 Compatibilized compositions, articles formed therefrom, and methods of manufacture thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-06-26 US disclosed
US-9969960-B2 Aqueous liquid composition COLGATE-PALMOLIVE COMPANY (US) 2018-05-15 US disclosed
EP-2550307-B1 MACRO-PHOTOINITIATORS AND CURABLE COMPOSITIONS THEREOF Henkel IP & Holding GmbH (DE) 2017-11-22 EP disclosed
US-9708487-B2 Aromatic polycarbonate resin composition and optical molded article IDEMITSU KOSAN CO., LTD. (JP) 2017-07-18 US disclosed
EP-1951815-B1 FLAME RESISTANT POLYMER BLENDS SABIC GLOBAL TECHNOLOGIES BV (NL) 2017-05-24 EP disclosed
US-9604910-B2 Composition of 5-nitrobenzoate derivatives as anti-metastatic agent that inhibits tumor cell-induced platelet aggregation CHANG GUNG UNIVERSITY (TW) 2017-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210107853-A1 SYNTHESIS OF MONO-CHLORINATED ACETOPHENONE ACACA, CYP51A1, ACACB ALDH1A1 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.